Chestnut Hill, MA, United States of America

James S Huston

This inventor holds 25 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Biotechnology Engineering. Top assignees: Creative Biomolecules, Inc., Chiron Corporation, Momenta Pharmaceuticals, Inc.. Active years: 1991-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James S Huston. Retrieved from https://idiyas.com/inventor/james-s-huston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2

Average Co-Inventor Count = 3.2

ph-index = 16

Forward Citations = 2,459(Granted Patents)

Location History:

Chester Hill, MA (US) (1999)
Chestnut Hill, MA (US) (1992 - 2001)
Newton, MA (US) (1991 - 2021)
Cambridge, MA (US) (2024)

Company Filing History:

17 out of 72

Creative Biomolecules, Inc.

Momenta Pharmaceuticals, Inc.

patents

4. 2 out of 1,217

The United States of America as Represented by the Department of Health

patents

5. 1 out of 1

Creative Biomoelcules, Inc.

Janssen Biotech, Inc.

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

Engineered Fc Constructs

Biosynthetic Binding Proteins

Recombinant Proteins

Antibody Analogues

Polypeptide Linkers

Cancer Marker

Target Cell Delivery

Immune Complex Removal

Fusion Proteins

Single-Chain Fv Molecules

Leader Sequences

Serine-Rich Peptides

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391759 - Methods related to engineered Fc constructs (2025-08-19),

2. 12071482 - Compositions and methods related to engineered Fc constructs (2024-08-27),

3. 11124573 - Compositions and methods related to engineered Fc constructs (2021-09-21),

4. 10239944 - Compositions and methods related to engineered Fc constructs (2019-03-26),

5. 7105638 - Product and process for the production, isolation, and purification of recombinant polypeptide (2006-09-12),

6. 6207804 - Genetically engineered antibody analogues and fusion proteins thereof (2001-03-27),

7. 5888773 - Method of producing single-chain Fv molecules (1999-03-30),

8. 5877305 - DNA encoding biosynthetic binding protein for cancer marker (1999-03-02),

9. 5861156 - Methods of delivering agents to target cells (1999-01-19),

10. 5837846 - Biosynthetic binding proteins for immuno-targeting (1998-11-17),

11. 5753204 - Biosynthetic binding proteins for immunotargeting (1998-05-19),

12. 5534254 - Biosynthetic binding proteins for immuno-targeting (1996-07-09),

13. 5525491 - Serine-rich peptide linkers (1996-06-11),

14. 5482858 - Polypeptide linkers for production of biosynthetic proteins (1996-01-09),

15. 5476786 - Biosynthetic antibody binding sites (1995-12-19),

Title: James S Huston: A Leading Innovator in Engineered Fc Constructs

Introduction: James S Huston, based in Chestnut Hill, MA, stands out as a prominent inventor with a remarkable portfolio of 24 patents. His contributions to the field of biotechnology, particularly in engineered Fc constructs, have propelled advancements in therapeutic applications.

Latest Patents: Huston's latest patents focus on compositions and methods related to engineered IgG Fc constructs. These inventions pertain to innovative compositions that involve one or more Fc domains, showcasing his expertise in the design and development of biologically relevant constructs.

Career Highlights: Over the years, James has made significant strides in his career. He has worked with reputable companies such as Creative Biomolecules, Inc. and Chiron Corporation. His experiences in these organizations have not only enriched his knowledge but also contributed to the growth of biopharmaceutical innovation.

Collaborations: Throughout his career, Huston has collaborated with a number of esteemed professionals in the field. Notable colleagues include Hermann Oppermann and Charles M Cohen, whose combined expertise has fostered a collaborative environment for breakthrough inventions.

Conclusion: James S Huston continues to be a pivotal figure in the development of engineered solutions within biotechnology. His numerous patents reflect his commitment to innovation and the advancement of therapeutic technologies, positioning him as a key player in the landscape of modern science.

Profile summary based on public USPTO records.